Abstract
Introduction Neoadjuvant therapy (NAT) is an emerging strategy for operable pancreatic ductal adenocarcinoma (PDAC). While NAT increases multimodal th......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
